Funding for this research was provided by:
Text and Data Mining valid from 2019-01-07
Received: 30 June 2018
Accepted: 26 December 2018
First Online: 7 January 2019
Ethics approval and consent to participate
: The study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Regional Ethics Committee (Approval number ETL R14131). The relatives of each study subject were contacted by the coroner (SG) and their consent sought before inclusion in the study.
: Consent was obtained from the relative of the study subject for publication of Fig. InternalRef removed.
: Tampere Heart Hospital Co. holds a patent on the vibration transmittance device, as agreed upon by the inventors (Nikolai Beev, Juha Hautalahti, Matti Tarkka, Jari Hyttinen, Jari Laurikka; U.S. Patent No. 9,788,726; EU: 11867251.8–1657 – EPO. PCT Pub No: WO2012/168534). The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.